Newsroom-Katalog
Zeit | Boehringer Ingelheim: Meldungen vom 25.10.2004 |
---|---|
08:10 | Boehringer Ingelheim Submits Marketing Authorisation Application to European Union and to the FDA for Investigational Anti-HIV Agent Tipranavir |
Zeit | Boehringer Ingelheim: Meldungen vom 25.10.2004 |
---|---|
08:10 | Boehringer Ingelheim Submits Marketing Authorisation Application to European Union and to the FDA for Investigational Anti-HIV Agent Tipranavir |